(A) Cases that have an important clinical impact: 1) Remarkable effects of a new therapy for gastric cancer; 2) Previously unreported adverse events in treatments for gastric cancer; 3) Novel suggestions or pitfalls in diagnosing gastric cancer; (B) Cases that may provide significant clues to ...
Mihaljevic AL, Friess H, Schuhmacher C (2013) Clinical trials in gastric cancer and the future. J Surg Oncol 107:289-297. doi:10.1002/jso.23120Mihaljevic AL, Friess H, Schuhmacher C (2013) Clinical trials in gastric cancer and the future. J Surg Oncol 107(3):289-297. doi:10. 1002/...
However, the results of the recent clinical trials revealed that splenectomy should be avoided in total gastrectomy with D2 lymphadenectomy for proximal gastric cancer and that bursectomy should be avoided in gastrectomy with D2 lymphadenectomy for resectable gastric cancer. Both splenectomy and burs...
Thereafter, additional benefit of trastuzumab combined with a cisplatin and either fluorouracil or capecitabine regimen against HER2-positive gastric cancer has been confirmed from the results of international clinical trials (ToGA study). Becasue combination of S-1 and cisplatin is a standard therapy ...
There is an abundance of ongoing clinical trials exploring a variety of pharmacologic agents for treating gastric cancer. Pharmacists play an integral role in collaborating with physicians to manage gastric cancer therapy. Through this multidisciplinary alliance, pharmacists enhance the prospects for favorabl...
The treatment landscape of gastric cancer has evolved significantly in the past few years, with the emergence of new immunotherapy and targeted therapies for patients at various stages of the disease (Fig.1). In this review, we systematically summarize the pivotal clinical trials in GC treatment ...
Efficacy and tolerability of chemotherapy in elderly patients with advanced oesophago-gastric cancer: A pooled analysis of three clinical trials Eur J Cancer, 42 (2006), pp. 827-834 View PDFView articleView in ScopusGoogle Scholar 37. F.J. Lacueva, R. Calpena, J. Medrano, et al. Follow...
The treatment landscape of gastric cancer has evolved significantly in the past few years, with the emergence of new immunotherapy and targeted therapies for patients at various stages of the disease (Fig.1). In this review, we systematically summarize the pivotal clinical trials in GC treatment ...
Randomized clinical trials in gastric cancer. A total of 52 prospective, randomized controlled trials (RCT), published from 1975 to 2000, were reviewed for gastric cancer. The primary focus of these ef... SM Weber,MS Karpeh - 《Surgical Oncology Clinics of North America》...
and postoperative chemotherapy. Repeat analysis of ctDNA during treatment can also track changes in tumor genomic profiles [26]. Molecular heterogeneity is a significant challenge in biomarker-based clinical trials for cancer patients [109]. Still, ctDNA analysis can help to avoid false negative resu...